Calorie-sweetened beverages and fructose: what have we learned 10 years later

被引:96
|
作者
Bray, G. A. [1 ]
Popkin, B. M. [2 ]
机构
[1] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA
[2] Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA
来源
PEDIATRIC OBESITY | 2013年 / 8卷 / 04期
关键词
Fructose; health risks; randomized clinical trials; sugar; RANDOMIZED CONTROLLED-TRIAL; HEALTHY-YOUNG MEN; BODY-WEIGHT; CORN SYRUP; ENERGY-INTAKE; METABOLIC SYNDROME; DIETARY FRUCTOSE; FOOD-INTAKE; TRIGLYCERIDE RESPONSES; INSULIN SENSITIVITY;
D O I
10.1111/j.2047-6310.2013.00171.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
BackgroundSugar-sweetened drinks and the fructose they provide are associated with several health problems. MethodsData from the Nielsen Homescan and product content were analysed for sweetener type using the Gladson Nutrition Database. Meta-analyses and randomized clinical trials were used to evaluate outcomes of beverage and fructose intake. ResultsOver 70% of all foods contain some amounts of added sugar, and consumption of soft drinks has increased fivefold since 1950. Meta-analyses suggest that consumption of sugar-sweetened beverages is related to the risk of diabetes, the metabolic syndrome and cardiovascular disease in adults and in children. Drinking two sugar-sweetened beverages per day for 6 months induced features of the metabolic syndrome and fatty liver. Randomized, controlled trials in children and adults lasting from 6 months to 2 years have shown that lowering the intake of soft drinks reduced weight gain. Genetic factors influence the weight gain when drinking soft drinks. ConclusionConsumption of calorie-sweetened beverages and the fructose they contain has continued to increase and may play a role in the epidemic of obesity, the metabolic syndrome and fatty liver disease. Reducing intake of soft drinks is associated with less weight gain and metabolic improvement as well.
引用
收藏
页码:242 / 248
页数:7
相关论文
共 50 条
  • [1] Breathing Not Properly 10 Years Later What We Have Learned and What We Still Need to Learn
    Maisel, Alan S.
    Daniels, Lori B.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (04) : 277 - 282
  • [2] The myotonic dystrophy gene: 10 years later, what have we learned about pathogenesis?
    Thornton, CA
    [J]. NEUROMUSCULAR DISORDERS, 2001, 11 (6-7) : 616 - 616
  • [3] THE TME TRIAL: WHAT HAVE WE LEARNED IN 10 YEARS?
    Marijnen, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S67 - S67
  • [4] The Day One Talk, 20 Years Later: What Have We Learned?
    Mack, Jennifer W.
    [J]. JCO ONCOLOGY PRACTICE, 2023, 19 (04) : 164 - +
  • [5] Fukushima Future Studies: five years later, what have we learned?
    Drollette, Dan, Jr.
    [J]. BULLETIN OF THE ATOMIC SCIENTISTS, 2016, 72 (02) : 97 - 104
  • [6] THE ARTERIAL PULMONARY CATHETER - WHAT HAVE WE LEARNED 20 YEARS LATER
    VILLAR, J
    [J]. MEDICINA CLINICA, 1992, 98 (07): : 254 - 256
  • [7] Chronic kidney disease 10 years on: what have we learned?
    Taal, Maarten W.
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2012, 21 (06): : 607 - 611
  • [8] Estrogens in males: what have we learned in the last 10 years?
    Rochira, V
    Granata, ARM
    Madeo, B
    Zirilli, L
    Rossi, G
    Carani, C
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2005, 7 (01) : 3 - 20
  • [9] 10 Years of progress in HF research—what have we learned?
    Henry Krum
    [J]. Nature Reviews Cardiology, 2014, 11 : 631 - 633
  • [10] Estrogens in males: what have we learned in the last 10 years?
    Vincenzo Rochira
    Antonio R. M. Granata
    Bruno Madeo
    Lucia Zirilli
    Giuseppina Rossi
    Cesare Carani
    [J]. Asian Journal of Andrology, 2005, (01) : 3 - 20